Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2011 | 04-2010 | 04-2009 | 04-2008 | 04-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,096,000 | 3,099,000 | 2,070,000 | 2,138,000 | 2,802,000 |
| Depreciation Amortization | 975,000 | 939,000 | 853,000 | 782,000 | 583,000 |
| Income taxes - deferred | 153,000 | 144,000 | -171,000 | -101,000 | -236,000 |
| Accounts receivable | -342,000 | -271,000 | 108,000 | -461,000 | -326,000 |
| Other Working Capital | -1,012,000 | 242,000 | 259,000 | -372,000 | -448,000 |
| Other Operating Activity | 871,000 | -22,000 | 759,000 | 1,503,000 | 604,000 |
| Operating Cash Flow | $3,741,000 | $4,131,000 | $3,878,000 | $3,489,000 | $2,979,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 275,000 | -3,687,000 | -115,000 | 2,124,000 | -943,000 |
| PPE Investments | -501,000 | -573,000 | -498,000 | -513,000 | -573,000 |
| Net Acquisitions | -1,332,000 | -350,000 | -1,624,000 | -4,221,000 | -8,000 |
| Purchase Sale Intangibles | N/A | -62,000 | -165,000 | -93,000 | -121,000 |
| Other Investing Activity | -176,000 | -149,000 | -503,000 | -180,000 | -177,000 |
| Investing Cash Flow | $-1,734,000 | $-4,759,000 | $-2,740,000 | $-2,790,000 | $-1,701,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,946,000 | -444,000 | -633,000 | 543,000 | 45,000 |
| Debt Issued | 1,000,000 | 3,000,000 | 1,250,000 | 300,000 | N/A |
| Debt Repayment | -2,603,000 | -20,000 | -300,000 | -12,000 | -1,880,000 |
| Common Stock Issued | 85,000 | 165,000 | 416,000 | 403,000 | 331,000 |
| Common Stock Repurchased | -1,140,000 | -1,030,000 | -759,000 | -1,544,000 | -1,039,000 |
| Dividend Paid | -969,000 | -907,000 | -843,000 | -565,000 | -504,000 |
| Other Financing Activity | -1,325,000 | 0 | 24,000 | 40,000 | 36,000 |
| Financing Cash Flow | $-2,006,000 | $764,000 | $-845,000 | $-835,000 | $-3,011,000 |
| Exchange Rate Effect | 62,000 | -7,000 | -82,000 | -60,000 | -5,000 |
| Beginning Cash Position | 1,254,000 | 1,271,000 | 1,060,000 | 1,256,000 | 2,994,000 |
| End Cash Position | 1,317,000 | 1,400,000 | 1,271,000 | 1,060,000 | 1,256,000 |
| Net Cash Flow | $63,000 | $129,000 | $211,000 | $-196,000 | $-1,738,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,741,000 | 4,131,000 | 3,878,000 | 3,489,000 | 2,979,000 |
| Capital Expenditure | -501,000 | -573,000 | -498,000 | -513,000 | -573,000 |
| Free Cash Flow | 3,240,000 | 3,558,000 | 3,380,000 | 2,976,000 | 2,406,000 |